References
- Schoenfield LJ, Lachin JM. Steering Committee of the National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study, a controlled trial of efficacy and safety. Ann Intern Med 1981: 95(3): 257–82
- Tangedahl TN, Carey WD, Ferguson DR, et al. Drug treatment and efficacy of chenodeoxycholic add in 97 patients with cholelithiasis and increased surgical risk. Dig Dis Sci 1983: 28(Jun): 545–51
- Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982: 307(13): 798–800
- Ransohoff DF, Grade WA, Wolfenson LB, et al. Prophylactic cholecystectomy or expectant management for silent gallstones: a decision analysis to assess survival Ann Intern Med 1983: 99(2): 199–204
- Walsh DB, Eckhauser FE, Ramsburgh SR, et al. Risk associated with diabetes mellitus in patients undergoing gallbladder surgery. Surgery 1982: 91(3): 254–7
- Carey WD, Tangedahl TN. Medical therapy for gallstones. 1. Rationale and indications. Postgrad Med 1982: 71(5): 163–72
- Maton PN, Iser JH, Reuben A, et al. Outcome of chenodeoxycholic add (CDCA) treatment in 125 patients with radiolucent gallstones. Medicine (Baltimore) 1982: 61(2): 86–97
- Jacobus DP, Trout JR, Greenwell BE, et al. The natural history and therapeutic response to chenodiol in patients with floatable stones In the National Cooperative Gallstone Study (NCGS). (Abstr) Gastroenterology 1983: 84: 1197
- Tangedahl TN, Carey WD. Medical therapy for gallstones. 2. Initiation and monitoring. Postgrad Med 1982: 71(5): 181–7